Search Results for: Redhill H. pylori

H. pylori treatment now available

Posted on March 29, 2020

Following US FDA approval (see here) Israel’s Redhill has launched its Talicia treatment for H.pylori (Helicobacter) infections in the US. RedHill’s expanded sales force will promote Talicia to approximately 25,000 gastroenterologists, primary care physicians and other healthcare providers. https://www.israel21c.org/israeli-pharma-company-launches-drug-for-h-pylori-in-us-market/

Posted in Economy & Business | Leave a comment

US approval for H. pylori treatment

Posted on November 10, 2019

The US FDA has given approval for Israel’s Redhill Biopharma to market its RHB-105 (Talicia) treatment for the treatment of Helicobacter pylori (H. pylori). It follows successful Phase 3 trials, as reported (here) previously. H. pylori affects some 2 million … Continue reading →

Posted in Israel's Medical Achievements | Leave a comment

Good results in H. pylori treatment

Posted on December 9, 2018

Israeli biotech Redhill announced positive top-line results from its confirmatory Phase 3 study using its TALICIA treatment for H. pylori Infection. Of 455 trial participants, the antibiotic-resistant infection was eradicated completely in 85% of cases compared to 58% using an … Continue reading →

Posted in Israel's Medical Achievements | Leave a comment

Successful trials for treatment of gastric infections

Posted on June 21, 2015

Israel’s Redhill Biopharma announced positive top-line results from its Phase III study with RHB-105 for treating Helicobacter pylori (H. pylori) infections. RHB-105 achieved 89.4% efficacy in eradicating H. pylori with no serious adverse events or unexpected safety issues. http://www.redhillbio.com/RedHill/Templates/showpage.asp?DBID=1&LNGID=1&TMID=178&FID=1358&PID=0&IID=1947

Posted in Israel's Medical Achievements | Leave a comment